Bayer backs off Teva's premature Yaz copy

Bayer withdrew its patent lawsuit against Teva Pharmaceutical Industries for allegedly infringing Bayer's Yaz contraceptive with its Gianvi generic, according to court documents. Report

Suggested Articles

Teva is reportedly going for a moonshot with a $15 billion drug offer to settle its opioid cases. It's a plan that might just work, one analyst said.

CSL has sued a former exec who its says stole thousands of key documents as he left for competitor Pharming.

Influential U.S. cost watchdog ICER gave its blessing to Johnson & Johnson and Amarin's CV drugs. But there's a big catch for both meds.